Cargando…
Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017
INTRODUCTION: Completeness of Global Burden of Disease (GBD) Study data is acknowledged as a limitation. To date, no study has evaluated this issue for low back pain, a leading contributor to disease burden globally. METHODS: We retrieved reports, in any language, based on citation details from the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130740/ https://www.ncbi.nlm.nih.gov/pubmed/34001521 http://dx.doi.org/10.1136/bmjgh-2021-005847 |
_version_ | 1783694584191123456 |
---|---|
author | Tamrakar, Mamata Kharel, Priti Traeger, Adrian Maher, Chris O'Keeffe, Mary Ferreira, Giovanni |
author_facet | Tamrakar, Mamata Kharel, Priti Traeger, Adrian Maher, Chris O'Keeffe, Mary Ferreira, Giovanni |
author_sort | Tamrakar, Mamata |
collection | PubMed |
description | INTRODUCTION: Completeness of Global Burden of Disease (GBD) Study data is acknowledged as a limitation. To date, no study has evaluated this issue for low back pain, a leading contributor to disease burden globally. METHODS: We retrieved reports, in any language, based on citation details from the GBD 2017 study website. Pairs of raters independently extracted the following data: number of prevalence reports tallied across countries, age groups, gender and years from 1987 to 2017. We also considered if studies enrolled a representative sample and/or used an acceptable measure of low back pain. RESULTS: We retrieved 488 country-level reports that provide prevalence data for 103 of 204 countries (50.5%), with most prevalence reports (61%) being for high-income countries. Only 16 countries (7.8%) have prevalence reports for each of the three decades of the GBD. Most of the reports (79%) did not use an acceptable measure of low back pain when estimating prevalence. CONCLUSION: We found incomplete coverage across countries and time, and limitations in the primary prevalence studies included in the GBD 2017 study. This means there is considerable uncertainty about GBD estimates of low back pain prevalence and the disease burden metrics derived from prevalence. |
format | Online Article Text |
id | pubmed-8130740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-81307402021-05-27 Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017 Tamrakar, Mamata Kharel, Priti Traeger, Adrian Maher, Chris O'Keeffe, Mary Ferreira, Giovanni BMJ Glob Health Original Research INTRODUCTION: Completeness of Global Burden of Disease (GBD) Study data is acknowledged as a limitation. To date, no study has evaluated this issue for low back pain, a leading contributor to disease burden globally. METHODS: We retrieved reports, in any language, based on citation details from the GBD 2017 study website. Pairs of raters independently extracted the following data: number of prevalence reports tallied across countries, age groups, gender and years from 1987 to 2017. We also considered if studies enrolled a representative sample and/or used an acceptable measure of low back pain. RESULTS: We retrieved 488 country-level reports that provide prevalence data for 103 of 204 countries (50.5%), with most prevalence reports (61%) being for high-income countries. Only 16 countries (7.8%) have prevalence reports for each of the three decades of the GBD. Most of the reports (79%) did not use an acceptable measure of low back pain when estimating prevalence. CONCLUSION: We found incomplete coverage across countries and time, and limitations in the primary prevalence studies included in the GBD 2017 study. This means there is considerable uncertainty about GBD estimates of low back pain prevalence and the disease burden metrics derived from prevalence. BMJ Publishing Group 2021-05-17 /pmc/articles/PMC8130740/ /pubmed/34001521 http://dx.doi.org/10.1136/bmjgh-2021-005847 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Tamrakar, Mamata Kharel, Priti Traeger, Adrian Maher, Chris O'Keeffe, Mary Ferreira, Giovanni Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017 |
title | Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017 |
title_full | Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017 |
title_fullStr | Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017 |
title_full_unstemmed | Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017 |
title_short | Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017 |
title_sort | completeness and quality of low back pain prevalence data in the global burden of disease study 2017 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130740/ https://www.ncbi.nlm.nih.gov/pubmed/34001521 http://dx.doi.org/10.1136/bmjgh-2021-005847 |
work_keys_str_mv | AT tamrakarmamata completenessandqualityoflowbackpainprevalencedataintheglobalburdenofdiseasestudy2017 AT kharelpriti completenessandqualityoflowbackpainprevalencedataintheglobalburdenofdiseasestudy2017 AT traegeradrian completenessandqualityoflowbackpainprevalencedataintheglobalburdenofdiseasestudy2017 AT maherchris completenessandqualityoflowbackpainprevalencedataintheglobalburdenofdiseasestudy2017 AT okeeffemary completenessandqualityoflowbackpainprevalencedataintheglobalburdenofdiseasestudy2017 AT ferreiragiovanni completenessandqualityoflowbackpainprevalencedataintheglobalburdenofdiseasestudy2017 |